QUICK LINKS
Heat shock protein 90 (Hsp90) is a molecular chaperone that modulates intracellular signaling and protein folding, trafficking, and turnover. Inhibitors of Hsp90, such as geldanamycin, have shown potential as anti-tumor agents. Benzisoxazole Hsp90 Inhibitor binds the N-terminal domain of Hsp90, efficiently displacing geldanamycin from the ATP binding site (IC50 = 30 nM) (1). It also inhibits the proliferation of several cancer cell lines (IC50 ~ 0.28 μM), promotes the degradation of the Hsp90 client proteins Her-2 and androgen receptor, and has no effect on a variety of kinases (1).
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Benzisoxazole Hsp90 Inhibitor, 1 mg | sc-223790 | 1 mg | $196.00 | |||
Benzisoxazole Hsp90 Inhibitor, 5 mg | sc-223790A | 5 mg | $885.00 |